See analyst estimates and all valuation multiples for Chemicals
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $235B | 7.1x | 18.1x | |
| $98.3B | 4.2x | 21.8x | |
| $82.1B | 6.8x | 16.0x | |
| $81.9B | 5.2x | 22.8x | |
| $66.0B | 1.0x | 7.9x | |
| $52.7B | 1.4x | 8.9x | |
| $50.9B | 3.0x | 7.7x | |
| $48.5B | 3.7x | 19.2x | |
| $43.3B | 1.0x | 7.9x | |
| $42.9B | n/a | n/a | |
| $40.6B | 1.5x | 8.3x | |
| $39.5B | 3.2x | 12.4x | |
| $37.6B | 1.5x | 7.0x | |
| $34.9B | 0.9x | 8.1x | |
| $33.3B | 1.0x | 9.9x | |
| $31.1B | 2.0x | 10.8x | |
| $30.5B | 2.3x | 13.5x | |
| $28.9B | 2.5x | 13.2x | |
| $27.8B | 6.7x | 18.8x | |
| $26.4B | 0.8x | 6.6x | |
| $24.7B | 6.2x | 33.8x | |
| $24.0B | 4.0x | 9.9x | |
| $19.4B | 3.6x | 11.3x | |
| $19.3B | 4.3x | 16.6x | |
| $18.3B | 1.7x | 10.9x | |
| $17.8B | 2.1x | 9.1x | |
| $17.7B | 1.7x | 7.6x | |
| $17.6B | 2.4x | 15.0x | |
| $16.6B | 1.3x | 6.9x | |
| $16.5B | 3.1x | 15.1x | |
| $16.3B | 7.1x | 24.6x | |
| $15.9B | 0.4x | 2.1x | |
| $15.5B | 1.7x | 8.6x | |
| $14.8B | 2.5x | 6.5x | |
| $14.4B | 1.0x | 12.1x | |
| $14.3B | 1.3x | 9.2x | |
| $14.2B | 2.7x | 12.7x | |
| $13.5B | 2.9x | 8.6x | |
| $13.5B | 2.7x | 10.2x | |
| $12.4B | 0.8x | 5.7x | |
| $11.6B | 4.0x | 10.8x | |
| $11.4B | 1.7x | 7.0x | |
| $11.0B | 0.8x | 5.4x | |
| $10.6B | 5.2x | 11.4x | |
| $9.3B | 0.5x | 6.0x | |
| $7.9B | n/a | n/a | |
| $7.8B | 1.8x | 8.6x | |
| $7.8B | 0.5x | 2.7x | |
| $6.5B | 3.1x | 9.6x | |
| $5.7B | 1.5x | 10.2x | |
| $5.1B | 5.4x | 20.0x | |
| $4.9B | 1.9x | 14.3x | |
| $4.8B | 0.5x | 6.4x | |
| $4.6B | 6.6x | 22.7x | |
| $3.9B | n/a | n/a | |
| $3.9B | 0.4x | 11.8x | |
| $3.5B | 13.2x | 48.1x | |
| $3.3B | 0.8x | 15.7x | |
| $3.2B | 5.2x | 28.7x | |
| $3.1B | 7.6x | 24.3x | |
| $2.6B | 0.8x | 144.9x | |
| $2.1B | 8.8x | 28.4x | |
| $2.0B | 0.7x | 6.2x | |
| $1.7B | 0.1x | 6.5x | |
| $1.7B | 0.4x | 2.9x | |
| $1.4B | 1.2x | 9.1x | |
| $1.3B | n/a | n/a | |
| $1.3B | 2.5x | n/a | |
| $1.2B | n/a | n/a | |
| $1.1B | 1.2x | 11.2x | |
| $1.1B | 0.7x | 7.2x | |
| $743M | 0.4x | 8.1x | |
| $594M | n/a | n/a | |
| $529M | 1.3x | 8.3x | |
| $341M | 0.6x | 7.6x | |
| $336M | 0.7x | 2.2x | |
| $300M | 1.4x | 8.2x | |
| $212M | 6.0x | -4.2x | |
| $208M | n/a | n/a | |
| $173M | n/a | n/a | |
| $85.9M | n/a | n/a | |
| $55.7M | 3693.2x | -10.8x | |
| $31.6M | 0.9x | 6.7x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals